OBJECTIVES: Forms (280 pieces) of patients with leukemia. This questionnaire was developed at the Department of Organization and Economy of Pharmacy of the National University of Pharmacy. We have interviewed patients from eight regions of the country. METHODS: A logical, comparative, mathematical-statistical and sociological methods of research RESULTS:  Patients with leukemia have been noted to "willingness to pay threshold". Patients had to be noted monthly single and regular payment. Regular payment should be made to patients with leukemia throughout the year every month. These indicators should determine the financial ability to pay for leukemia patients using innovative medical technology in the treatment. Analysis of the indicator "threshold willingness to pay" was carried out by different variables. Let us analyze the indicator "threshold willingness to pay" depending on the sex of the patient. We have found the following. The average value of "threshold of readiness" index pay for the use of innovative medical technology in males was significantly higher than that of women. For women, the figure was US $ 172.97 (one-time payment) and 154.94 USD (regular payment). The average value of the index "willingness to pay threshold" for a group of male respondents was US $ 241.30 (one-time payment) and 235.17 USD (regular monthly payment). By comparing the figures the average value of the "willingness to pay threshold" for a group of men and women following. Index variation range according to the one-time payments equaled US Dollar 68.33 (39.50%). Index variation equal to 80.23 US dollars (51.78%). CONCLUSIONS: It has been established that men are significantly higher estimated value of one year of quality life saved and the need to use for this purpose an innovative medical technology than women. The results of these studies will be used in the development of approaches to improve the process for leukemia patient’s effective anticancer drugs.